Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic ShockPierre‐François Laterre, Karsten Jacobsen, Roger Lewis et al.|JAMA|2019Cited by 141
Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trialBruno François, Thorbjørn Grøfte, Simon Lambden et al.|The Lancet Respiratory Medicine|2023Cited by 76
Sedation practice and discomfort during withdrawal of mechanical ventilation in critically ill patients at end-of-life: a post-hoc analysis of a multicenter studyJean Reignier, René Robert, Amélie Le Gouge et al.|Intensive Care Medicine|2020Cited by 34
Relying on pulse oximetry to avoid hypoxaemia and hyperoxia: A multicentre prospective cohort study in patients with circulatory failureThierry Boulain, Delphine Chatellier, Mai-Anh Nay et al.|Australian Critical Care|2022Cited by 6